Recently, fucoidan has been shown to inhibit transforming growth factor beta 1 (TGF-β1) secretion and affect cancer cell viability through increased expression of C-type lectin-like receptor 2 (CLEC-2) in several gastric carcinoma cells, demonstrating its anti-cancer potential [92]. This evidence concerns the gene CLEC1B and cancer.